Research Advances Knowledge in Cancer Therapy with SHP2 Modulator

Strategic Insights -

Research at Jinzhou Medical University has provided new insights into the role of Src homology phosphotyrosyl phosphatase 2 (SHP2) in cancer therapy. According to a recent study, SHP2 modulators have shown promise as a tumor therapeutic target due to their ability to regulate tumor cell growth and proliferation, as well as mediate immune escape. The study's authors, from Jinzhou Medical University, comprehensively reviewed the research progress on SHP2 regulators and discussed their biological functions in the pathological process of tumors.

Key Takeaways:

  • SHP2 is a protein tyrosine phosphatase that catalyzes the dephosphorylation of proteins at the tyrosine site, which plays a dual biological function in tumor regulation.
  • SHP2 modulators have shown promise as a tumor therapeutic target due to their ability to regulate tumor cell growth and proliferation and mediate immune escape.
  • The research reviewed the structure and basic mechanism of SHP2 in detail and discussed its biological functions in the pathological process of tumors.
  • Small molecule inhibitors and biologics are being developed as potential SHP2 modulators, which may offer new therapeutic options for cancer treatment.
  • Despite the progress made, challenges and limitations remain in the development of SHP2 modulators for tumor immunotherapy.
  • The study's authors emphasized the need for further research to overcome these challenges and translate SHP2 modulators into clinical applications.

Statistics:

  • 2025: The year in which the study was published.
  • 174():02019: The volume and article number of the journal article in which the study was published.
  • 10.1051/bioconf/202517402019: The DOI of the journal article.
  • 2 (BIO Web of Conferences - http://www.bio-conferences.org): The IOC of the journal article publisher.
  • 2025: The year the research was conducted.

Sources:

  • Research Progress of SHP2 Modulator in Anti-Tumor Biological Mechanism. BIO Web of Conferences, 2025,174():02019.
  • https://doi-org.sdpl.idm.oclc.org/10.1051/bioconf/202517402019
  • Department of Pharmacy, Jinzhou Medical University
  • EDP Sciences (publisher for BIO Web of Conferences)
  • NewsRx. Jinzhou Medical University Researcher Advances Knowledge in Cancer Therapy (Research Progress of SHP2 Modulator in Anti-Tumor Biological Mechanism). Immunotherapy Weekly. June 11, 2025; p 2078.